Steitz AM, Reinartz S, Beutgen VM, Müller R, Pogge von Strandmann E, Gómez-Serrano M. Elucidating the mechanistic role of ovarian cancer biomarkers: Lessons learnt from affinity-proteomics. Crit Rev Oncol Hematol. 2025 Jun 30:214:104823. doi: 10.1016/j.critrevonc.2025.104823
* Karimova AF, Khalitova AR, Suezov R, Markov N, Mukhamedshina Y, Rizvanov AA, Huber M, Simon HU, Brichkina A. Immunometabolism of tumor-associated macrophages: A therapeutic perspective. Eur J Cancer. 2025 May 2;220:115332. doi: 10.1016/j.ejca.2025.115332.
Geller M, Cao Y, Simon C, Stielow B, Xu J, Wei P, Nist A, Rohner I, Jeude LM, Huber T, Stiewe T, Wang Z, Liefke R. Cooperation of a polymerizing SAM domain and an intrinsically disordered region enables full SAMD1 function on chromatin. Nucleic Acid Res. 2025 Mar 20;53(6):gkaf259. doi: 10.1093/nar/gkaf259
* Ems M, Brichkina A, Lauth M. A safe haven for cancer cells: tumor plus stroma control by DYRK1B. Oncogene. 2025 Feb;44(6):341-347. doi: 10.1038/s41388-025-03275-6.
Gremke N, Besong I, Stroh A, von Wichert L, Witt M, Elmshäuser S, Wanzel M, Fromm MF, Taudte RV, Schmatloch S, Karn T, Reinisch M, Hirmas N, Loibl S, Wündisch T, Litmeyer AS, Jank P, Denkert C, Griewing S, Wagner U, Stiewe T. Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs. Signal Transduct Target Ther. 2025 Mar 21;10(1):92. doi: 10.1038/s41392-025-02180-4
Leib L, Juli J, Jurida L, Mayr-Buro C, Priester J, Weiser H, Wirth S, Hanel S, Heylmann D, Weber A, Schmitz ML, Papantonis A, Bartkuhn M, Wilhelm J, Linne U, Meier-Soelch J, Kracht M. The proximity-based protein interactome and regulatory logics of the transcription factor p65 NF-κB/RELA. EMBO Rep. 2025 Feb;26(4):1144-1183. doi: 10.1038/s44319-024-00339-8
Preußer C, Gläser M, Graumann J, Szymański W, Bachurski D, Gómez-Serrano M, Jacob R, Reinartz S, Pogge von Strandmann E. Extracellular vesicles from ovarian cancer tumor spheroids harbor disease-related and survival-associated proteins. Extracell Vesicles CircNucleic Acids. 2025;6:677-86. doi: 10.20517/evcna.2025.70
Dreute J, Stengel J, Becher J, van den Borre D, Pfisterer M, Bartkuhn M, Beutgen VM, Ndreshkjana B, Gärtner U, Graumann J, Huck M, Klatt S, Leff C, Farin HF, Nist A, Schmitz R, Stiewe T, Teply-Szymanski, Wilhelm J, Cabrera-Orefice A, Schmitz ML. Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes. Cell Death Differ. 2025 Dec;32(12):2239-2256. doi: 10.1038/s41418-025-01532-5.
* Kegel NB, Yilmaz Demirel N, Glatter T, Höfer K, Kaufmann A, Bauer S. Proteins are a source of glycans found in preparations of glycoRNA. Exp Mol Med. 2025 Nov;57(11):2505-2516. doi: 10.1038/s12276-025-01575-1.
Funk JS, Klimovich M, Drangenstein D, Pielhoop O, Hunold P, Borowek A, Noeparast M, Pavlakis E, Neumann M, Balourdas DI, Kochhan K, Merle N, Bullwinkel I, Wanzel M, Elmshäuser S, Teply-Szymanski J, Nist A, Procida T, Bartkuhn M, Humpert K, Mernberger M, Savai R, Soussi T, Joerger AC, Stiewe T. Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations. Nat Genet. 2025 Jan;57(1):140-153. doi: 10.1038/s41588-024-02039-4.
* Kegel NB, Kaufmann A, Matrosovich M, Bauer S, Dorna J. Decomposition of L-glutamine and accumulation of ammonium in cell culture media inhibit infectivity of influenza viruses. Virology. 2025 Jan;602:110314. doi: 10.1016/j.virol.2024.110314.
* publication without GRK 2573 funding -- associated PhD